scholarly journals AEGS: identifying aberrantly expressed gene sets for differential variability analysis

2017 ◽  
Vol 34 (5) ◽  
pp. 881-883 ◽  
Author(s):  
Jinting Guan ◽  
Moliang Chen ◽  
Congting Ye ◽  
James J Cai ◽  
Guoli Ji
2014 ◽  
Vol 13s5 ◽  
pp. CIN.S14066 ◽  
Author(s):  
Bahman Afsari ◽  
Donald German ◽  
Elana J. Fertig

Analysis of gene sets can implicate activity in signaling pathways that is responsible for cancer initiation and progression, but is not discernible from the analysis of individual genes. Multiple methods and software packages have been developed to infer pathway activity from expression measurements for set of genes targeted by that pathway. Broadly, three major methodologies have been proposed: over-representation, enrichment, and differential variability. Both over-representation and enrichment analyses are effective techniques to infer differentially regulated pathways from gene sets with relatively consistent differentially expressed (DE) genes. Specifically, these algorithms aggregate statistics from each gene in the pathway. However, they overlook multivariate patterns related to gene interactions and variations in expression. Therefore, the analysis of differential variability of multigene expression patterns can be essential to pathway inference in cancers. The corresponding methodologies and software packages for such multivariate variability analysis of pathways are reviewed here. We also introduce a new, computationally efficient algorithm, expression variation analysis (EVA), which has been implemented along with a previously proposed algorithm, Differential Rank Conservation (DIRAC), in an open source R package, gene set regulation (GSReg). EVA inferred similar pathways as DIRAC at reduced computational costs. Moreover, EVA also inferred different dysregulated pathways than those identified by enrichment analysis.


2008 ◽  
Vol 24 (13) ◽  
pp. i390-i398 ◽  
Author(s):  
J. W.K. Ho ◽  
M. Stefani ◽  
C. G. dos Remedios ◽  
M. A. Charleston

2013 ◽  
Vol 6 (1) ◽  
pp. 430 ◽  
Author(s):  
Vivek Jayaswal ◽  
Sarah-Jane Schramm ◽  
Graham J Mann ◽  
Marc R Wilkins ◽  
Yee Yang

2017 ◽  
Author(s):  
T Itzel ◽  
R Spang ◽  
T Maass ◽  
S Munker ◽  
HJ Schlitt ◽  
...  

2018 ◽  
Vol 21 (2) ◽  
pp. 74-83
Author(s):  
Tzu-Hung Hsiao ◽  
Yu-Chiao Chiu ◽  
Yu-Heng Chen ◽  
Yu-Ching Hsu ◽  
Hung-I Harry Chen ◽  
...  

Aim and Objective: The number of anticancer drugs available currently is limited, and some of them have low treatment response rates. Moreover, developing a new drug for cancer therapy is labor intensive and sometimes cost prohibitive. Therefore, “repositioning” of known cancer treatment compounds can speed up the development time and potentially increase the response rate of cancer therapy. This study proposes a systems biology method for identifying new compound candidates for cancer treatment in two separate procedures. Materials and Methods: First, a “gene set–compound” network was constructed by conducting gene set enrichment analysis on the expression profile of responses to a compound. Second, survival analyses were applied to gene expression profiles derived from four breast cancer patient cohorts to identify gene sets that are associated with cancer survival. A “cancer–functional gene set– compound” network was constructed, and candidate anticancer compounds were identified. Through the use of breast cancer as an example, 162 breast cancer survival-associated gene sets and 172 putative compounds were obtained. Results: We demonstrated how to utilize the clinical relevance of previous studies through gene sets and then connect it to candidate compounds by using gene expression data from the Connectivity Map. Specifically, we chose a gene set derived from a stem cell study to demonstrate its association with breast cancer prognosis and discussed six new compounds that can increase the expression of the gene set after the treatment. Conclusion: Our method can effectively identify compounds with a potential to be “repositioned” for cancer treatment according to their active mechanisms and their association with patients’ survival time.


Sign in / Sign up

Export Citation Format

Share Document